Cardiorespiratory Articles & Analysis
2 articles found
The FDA's Center for Drug Evaluation and Research (CDER) regulatory approval of a total of 26 NME (New Molecular Entity) drugs in the first half of 2023. It is worth noting that the 26 drugs approved include 4 peptide drugs, accounting for 15% of the total. In the past 2022, the FDA has approved only three peptide drugs: Tirzepatide, Lutetium 177Lu Vipivotide Tetraxetan and Terlipressin, of which ...
At the moment, there’s a wide range of rehabilitation aids available for people with impaired mobility: diverse walkers, light and robust crutches, tons of various wheelchairs. All of them have certain flaws and weaknesses. For instance, state-of-the-art wheelchairs make it possible to go in for sports, travel at a rather high speed, and are user-friendly, but all of those aspects ...